Derek M. Meisner, Chief Legal Officer & Corporate Secretary at Acumen Pharmaceuticals, Inc. (ABOS), sold 8,933 shares at $3.48 ($31K) on 2024-01-19, disclosed to the SEC on 2024-01-19.
Scheduled sale ($31k) by Chief Legal Officer & Corporate Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ABOS | SELL | 2026-01-28 | $107K | — | Filing → |
| ABOS | SELL | 2026-01-23 | $31K | — | Filing → |
| ABOS | SELL | 2026-01-12 | $182K | — | Filing → |